206 related articles for article (PubMed ID: 12161545)
1. Comment: the methionine 196 arginine polymorphism in exon 6 of the TNF receptor 2 gene (TNFRSF1B) is associated with the polycystic ovary syndrome and hyperandrogenism.
Peral B; San Millán JL; Castello R; Moghetti P; Escobar-Morreale HF
J Clin Endocrinol Metab; 2002 Aug; 87(8):3977-83. PubMed ID: 12161545
[TBL] [Abstract][Full Text] [Related]
2. TNF-alpha and hyperandrogenism: a clinical, biochemical, and molecular genetic study.
Escobar-Morreale HF; Calvo RM; Sancho J; San Millán JL
J Clin Endocrinol Metab; 2001 Aug; 86(8):3761-7. PubMed ID: 11502808
[TBL] [Abstract][Full Text] [Related]
3. Frequency of adiponectin gene polymorphisms in polycystic ovary syndrome and the association with serum adiponectin, androgen levels, insulin resistance and clinical parameters.
Demirci H; Yilmaz M; Ergun MA; Yurtcu E; Bukan N; Ayvaz G
Gynecol Endocrinol; 2010 May; 26(5):348-55. PubMed ID: 20388053
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation in exon 17 of INSR is associated with insulin resistance and hyperandrogenemia among lean Indian women with polycystic ovary syndrome.
Mukherjee S; Shaikh N; Khavale S; Shinde G; Meherji P; Shah N; Maitra A
Eur J Endocrinol; 2009 May; 160(5):855-62. PubMed ID: 19211708
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome.
Gambineri A; Vicennati V; Genghini S; Tomassoni F; Pagotto U; Pasquali R; Walker BR
J Clin Endocrinol Metab; 2006 Jun; 91(6):2295-302. PubMed ID: 16551740
[TBL] [Abstract][Full Text] [Related]
6. Androgen levels and metabolic parameters are associated with a genetic variant of F13A1 in women with polycystic ovary syndrome.
Schweighofer N; Lerchbaum E; Trummer O; Schwetz V; Pilz S; Pieber TR; Obermayer-Pietsch B
Gene; 2012 Aug; 504(1):133-9. PubMed ID: 22565190
[TBL] [Abstract][Full Text] [Related]
7. Variants in SULT2A1 affect the DHEA sulphate to DHEA ratio in patients with polycystic ovary syndrome but not the hyperandrogenic phenotype.
Louwers YV; de Jong FH; van Herwaarden NA; Stolk L; Fauser BC; Uitterlinden AG; Laven JS
J Clin Endocrinol Metab; 2013 Sep; 98(9):3848-55. PubMed ID: 23861462
[TBL] [Abstract][Full Text] [Related]
8. Identification of TNFRSF1B as a novel modifier gene in familial combined hyperlipidemia.
Geurts JM; Janssen RG; van Greevenbroek MM; van der Kallen CJ; Cantor RM; Bu X; Aouizerat BE; Allayee H; Rotter JI; de Bruin TW
Hum Mol Genet; 2000 Sep; 9(14):2067-74. PubMed ID: 10958645
[TBL] [Abstract][Full Text] [Related]
9. CAG repeat polymorphism in androgen receptor gene is not directly associated with polycystic ovary syndrome but influences serum testosterone levels.
Skrgatic L; Baldani DP; Cerne JZ; Ferk P; Gersak K
J Steroid Biochem Mol Biol; 2012 Feb; 128(3-5):107-12. PubMed ID: 22107839
[TBL] [Abstract][Full Text] [Related]
10. [Polymorphism in CYP11alpha and CYP17 genes and the etiology of hyperandrogenism in patients with polycystic ovary syndrome].
Pérez MS; Cerrone GE; Benencia H; Márquez N; De Piano E; Frechtel GD
Medicina (B Aires); 2008; 68(2):129-34. PubMed ID: 18499961
[TBL] [Abstract][Full Text] [Related]
11. Association of the 17-hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) with hyperandrogenemia in polycystic ovary syndrome (PCOS).
Marioli DJ; Saltamavros AD; Vervita V; Koika V; Adonakis G; Decavalas G; Markou KB; Georgopoulos NA
Fertil Steril; 2009 Aug; 92(2):648-52. PubMed ID: 18692800
[TBL] [Abstract][Full Text] [Related]
12. Association study of +45G15G(T/G) and +276(G/T) polymorphisms in the adiponectin gene in patients with polycystic ovary syndrome.
Li L; Yun JH; Lee JH; Song S; Choi BC; Baek KH
Int J Mol Med; 2011 Feb; 27(2):283-7. PubMed ID: 21125210
[TBL] [Abstract][Full Text] [Related]
13. The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome.
Escobar-Morreale HF; Luque-Ramírez M; San Millán JL
Endocr Rev; 2005 Apr; 26(2):251-82. PubMed ID: 15561799
[TBL] [Abstract][Full Text] [Related]
14. Common variants in the sex hormone-binding globulin gene (SHBG) and polycystic ovary syndrome (PCOS) in Mediterranean women.
Martínez-García MÁ; Gambineri A; Alpañés M; Sanchón R; Pasquali R; Escobar-Morreale HF
Hum Reprod; 2012 Dec; 27(12):3569-76. PubMed ID: 23001781
[TBL] [Abstract][Full Text] [Related]
15. [Polymorphism in insulin receptor gene exon 17 in women with polycystic ovary syndrome].
Jin L; Huang HF; Jin F; Qian YL
Zhonghua Fu Chan Ke Za Zhi; 2005 May; 40(5):323-6. PubMed ID: 15938783
[TBL] [Abstract][Full Text] [Related]
16. Serum asymmetric dimethylarginine, apelin, and tumor necrosis factor-α levels in non-obese women with polycystic ovary syndrome.
Choi YS; Yang HI; Cho S; Jung JA; Jeon YE; Kim HY; Seo SK; Lee BS
Steroids; 2012 Nov; 77(13):1352-8. PubMed ID: 22944040
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study.
Escobar-Morreale HF; Villuendas G; Botella-Carretero JI; Alvarez-Blasco F; Sanchón R; Luque-Ramírez M; San Millán JL
Hum Reprod; 2006 Sep; 21(9):2257-65. PubMed ID: 16675483
[TBL] [Abstract][Full Text] [Related]
18. Association of FTO gene with hyperandrogenemia and metabolic parameters in women with polycystic ovary syndrome.
Wehr E; Schweighofer N; Möller R; Giuliani A; Pieber TR; Obermayer-Pietsch B
Metabolism; 2010 Apr; 59(4):575-80. PubMed ID: 19913856
[TBL] [Abstract][Full Text] [Related]
19. The R453Q and D151A polymorphisms of hexose-6-phosphate dehydrogenase gene (H6PD) influence the polycystic ovary syndrome (PCOS) and obesity.
Martínez-García MA; San-Millán JL; Escobar-Morreale HF
Gene; 2012 Apr; 497(1):38-44. PubMed ID: 22306327
[TBL] [Abstract][Full Text] [Related]
20. A Missense Variant rs4645843 in TNF-α Gene Is a Risk Factor of Polycystic Ovary Syndrome in the Uygur Population.
Li S; Zhao L; Wan XH
Tohoku J Exp Med; 2017 Oct; 243(2):95-100. PubMed ID: 28993561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
